ResMed Stock Up On Q2 Beat, But Growth Still Slow
Medical device maker ResMed (RMD) jumped in morning trading Friday after its fiscal Q2 results beat estimates late Thursday. ResMed, which makes devices and systems to treat sleep disorders, reported earnings excluding one-time items of 69 cents a share in the quarter ended Dec. 31. That’s up 6% from the year-earlier quarter and 3 cents over analysts’ consensus, according to Thomson Reuters. Sales climbed 7% to $454.5 million, topping consensus by